Table 2.

Adverse events (AEs) (≥2 participants).

Event, n (%)	Elamipretide (n = 30)	Placebo (n = 30)
Injection site reactions
Erythema	17 (56.7)	1 (3.3)
Pruritus	14 (46.7)	0 (0)
Pain	6 (20.0)	1 (3.3)
Urticaria	6 (20.0)	0 (0)
Irritation	3 (10.0)	1 (3.3)
Bruising	2 (6.7)	2 (6.7)
Dizziness	3 (10.0)	1 (3.3)
Abdominal pain	2 (6.7)	1 (3.3)
Dysarthria	2 (6.7)	0 (0)
Urinary tract infection	2 (6.7)	0 (0)
Viral upper respiratory tract infection	2 (6.7)	0 (0)
Diarrhoea	1 (3.3)	2 (6.7)
Fall	1 (3.3)	3 (10.0)
Muscle spasms	1 (3.3)	2 (6.7)
Back pain	0 (0)	2 (6.7)
Headache	0 (0)	2 (6.7)